Differing Mechanisms of Action of Angiotensin-Converting Enzyme Inhibition in Black and White Hypertensive Patients
The DOI matches its Crossref record.
Abstract
The antihypertensive effect of the angiotensin-converting enzyme inhibitor trandolapril administered in doses of 1, 2, and 4 mg/d was compared in 207 white patients and 91 black patients with mild to moderate hypertension following a double-blind, randomized, placebo-controlled, parallel study design. Trandolapril is a prodrug that is rapidly hydrolyzed to its active diacid metabolite, trandolaprilat. After 6 weeks of double-blind treatment, trandolapril lowered baseline sitting diastolic pressure in both white and black patients. A comparison of the antihypertensive response of the two populations revealed that the black patients required between two and four times the dose of trandolapril to obtain a response similar to that observed in the white patients. A dose of 1 mg/d trandolapril resulted in a 6.1 mm Hg mean decrease in baseline sitting diastolic pressure for white patients; a similar response (−6.5 mm Hg) was observed in the black patients at 4 mg/d. In contrast to the population differences in blood pressure, the decreases in angiotensin-converting enzyme activity were similar for both populations. An evaluation of trandolaprilat levels revealed that there were no racial differences in the trandolaprilat concentrations required to achieve a given degree of angiotensin-converting enzyme inhibition. Therefore, it appears that the antihypertensive response of black patients is not completely explained by a reduction in angiotensin-converting enzyme activity. The lack of response at a lower dose but increasing response at a higher dose could reflect another vasodepressor activity of trandolapril or just be evidence of reduced sensitivity of high blood pressure in blacks to angiotensin-converting enzyme inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
The renin-angiotensin-aldosterone system: a specific target for hypertension management
Weir, M. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00103-x · Cited by 407
Self-citationRacial Differences in Hypertension: Implications for High Blood Pressure Management
Lackland, D. T. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000308 · Cited by 397
Racial Differences in the Outcome of Left Ventricular Dysfunction
Dries, D. L., Exner, D. V., Gersh, B. J., Cooper, H. A., Carson, P. E., & Domanski, M. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902253400804 · Cited by 368
Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
Law, M., Wald, N., & Morris, J. (2003) · Health Technology Assessment · doi:10.3310/hta7310 · Cited by 327
PAN, Y., & JACKSON, R. T. (2008) · Epidemiology and Infection · doi:10.1017/s095026880700831x · Cited by 294
Increased sensitivity to bradykinin among African Americans
Gainer, J. V., Nadeau, J. H., Ryder, D., & Brown, N. J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70151-3 · Cited by 89
The DASH diet enhances the blood pressure response to losartan in hypertensive patients
Conlin, P. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00056-6 · Cited by 76
Van Guilder, G. P., Pretorius, M., Luther, J. M., Byrd, J. B., Hill, K., Gainer, J. V., & Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102574 · Cited by 42
Metadata
- Authors
- Weir, M. R., Gray, J. M., Paster, R., & Saunders, E.
- Venue
- Hypertension
- Published
- 1995-07
- Volume
- 26
- Issue
- 1
- Pages
- 124-130
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2119462953
- Cited by
- 136
- References
- 0
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.